IBIO
iBio, Inc. Common StockNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$83.96M
P/E Ratio
—
EPS
$-0.56
Beta
1.24
52W High
$3.82
52W Low
$0.56
50-Day MA
$1.81
200-Day MA
$1.71
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
0.00
About iBio, Inc. Common Stock
iBio, Inc., a biotech company, provides contract development and manufacturing services to outside partners and customers in the United States. The company is headquartered in New York, New York.
Fundamentals
| Revenue (TTM) | 300,000 |
| Gross Profit (TTM) | 300,000 |
| EBITDA | $-28.27M |
| Operating Margin | -9653.00% |
| Return on Equity | -62.10% |
| Return on Assets | -34.50% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $2.25 |
| Price-to-Book | 1.08 |
| Price-to-Sales (TTM) | 279.86 |
| EV/Revenue | 37.45 |
| EV/EBITDA | -1.59 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 14.30% |
| Shares Outstanding | $49.68M |
| Float | $39.32M |
| % Insiders | 1.71% |
| % Institutions | 48.65% |
Historical Volatility
HV 10-Day
64.31%
HV 20-Day
84.06%
HV 30-Day
82.09%
HV 60-Day
86.75%
HV Rank
17.1%
Volatility is currently contracting
Analyst Ratings
Consensus ($5.53 target)
6
BuyMore HEALTHCARE Stocks
Data last updated: 6/13/2026